|
|
 |
|
 |
September 19, 2005
MDX Medical Hires VP Technology and NIRS Development Team
Vancouver, BC - (September 19, 2005) MDX Medical Inc. (TSX.V: MDX) announced today that it has completed the hiring of the core team required to develop its NIRS (Near Infra Red Spectrophotometry) technology. The team working with UBC researchers will focus immediately on the advancement of the pre-commercial NIRS device. The NIRS technology is a breakthrough in bladder care providing non-invasive monitoring in the diagnosis of urinary incontinence and bladder dysfunction.
The team of engineers will be led by Dr. Luya Li, Vice President Technology, who has a PhD in Electrical Engineering and over 20 years experience in developing leading edge technologies. Dr. Li was most recently a senior technical manager at VSM MedTech Ltd. where he led the development of a medical device incorporating near-infrared optical sensing technology through its early stages, clinical studies and collaboration with development partners. He has also held a variety of senior technical positions in research institutions and industrial high tech companies. Dr. Li has been issued three US patents and another three patent applications are pending in the medical device field.
Mr. Barry Allen, President and CEO of MDX Medical stated "The addition of Dr. Li and his team will accelerate MDX's completion of its business objectives and technology milestones. Having worked with Dr. Li in the past, I am confident that his direct and relevant experience and knowledge in optical sensing and medical devices will be a key addition to MDX and a real asset as we commercialize the NIRS technology. "
About MDX Medical
MDX Medical Inc.'s focus is on the commercialization of novel, innovative and leading edge medical device technologies for improved diagnosis and treatment of prominent health disorders. The Company�s business strategy is to acquire and commercialize high potential technologies that have reached the "proof of feasibility" or later stages of product development. For more information about MDX, please visit our website at: www.mdxmedical.com.
On behalf of the Board,
"Barry Allen"
President & CEO
MDX Medical Inc.
Certain information contained in this press release may be forward looking and is subject to unknown risks, which could cause actual results to differ materially from those, set forth or implied herein. Although the Company believes that the expectations reflected in such forward looking statements are reasonable, it can give no assurance that such expectations will prove correct.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Larry Horsburgh
Phone: (604) 694-7770, Ext. 112
Email: lhorsburgh@mdxmedical.com |
|  |
|
